MUNARI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 1.808
EU - Europa 1.769
AS - Asia 1.321
SA - Sud America 175
AF - Africa 45
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.125
Nazione #
US - Stati Uniti d'America 1.763
RU - Federazione Russa 736
SG - Singapore 489
CN - Cina 380
GB - Regno Unito 294
IT - Italia 205
HK - Hong Kong 131
BR - Brasile 130
SE - Svezia 127
VN - Vietnam 125
DE - Germania 95
IE - Irlanda 76
FR - Francia 69
FI - Finlandia 64
KR - Corea 48
IN - India 31
BD - Bangladesh 30
UA - Ucraina 29
CA - Canada 19
MX - Messico 18
ES - Italia 15
JP - Giappone 14
EC - Ecuador 13
TR - Turchia 11
AR - Argentina 10
NL - Olanda 10
BE - Belgio 9
ID - Indonesia 9
LT - Lituania 8
PL - Polonia 8
ZA - Sudafrica 8
NG - Nigeria 7
VE - Venezuela 7
AU - Australia 6
BJ - Benin 6
PH - Filippine 6
UZ - Uzbekistan 6
CO - Colombia 5
TG - Togo 5
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
AZ - Azerbaigian 3
CH - Svizzera 3
CL - Cile 3
IQ - Iraq 3
MY - Malesia 3
NO - Norvegia 3
PK - Pakistan 3
UY - Uruguay 3
AL - Albania 2
AT - Austria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GN - Guinea 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
NP - Nepal 2
PS - Palestinian Territory 2
PT - Portogallo 2
SA - Arabia Saudita 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CY - Cipro 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
NE - Niger 1
NI - Nicaragua 1
OM - Oman 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.125
Città #
Moscow 267
Southend 248
Singapore 238
Ashburn 215
Chandler 210
San Jose 175
Dallas 168
Hong Kong 131
Jacksonville 96
Woodbridge 94
Dublin 75
Verona 75
Beijing 64
Ann Arbor 59
Council Bluffs 51
Ho Chi Minh City 47
The Dalles 45
Los Angeles 43
New York 38
Houston 30
Jinan 28
Lawrence 28
Princeton 28
Helsinki 26
Nanjing 22
Columbus 20
Munich 20
Santa Clara 18
Hanoi 17
Redmond 17
São Paulo 17
Seoul 16
Wilmington 15
Bologna 14
Buffalo 14
Shenyang 14
Sindelfingen 14
Tokyo 14
Rome 13
Frankfurt am Main 12
Redondo Beach 12
Tianjin 12
Turku 12
Hebei 11
London 11
Brussels 8
Denver 8
Dong Ket 8
Jiaxing 8
Naples 8
Ningbo 8
Norwalk 8
Stockholm 8
Zhengzhou 8
Abuja 7
Boardman 7
Brooklyn 7
Mexico City 7
Milan 7
Cotonou 6
Fuzhou 6
Hangzhou 6
Johannesburg 6
Madrid 6
Manchester 6
Montreal 6
Nanchang 6
Phoenix 6
Taiyuan 6
Tashkent 6
Warsaw 6
Wuhan 6
Changsha 5
Chennai 5
Lancaster 5
Lomé 5
Orem 5
Saint Louis 5
Taizhou 5
Amman 4
Buttapietra 4
Cagliari 4
Da Nang 4
Dongguan 4
Guayaquil 4
Haikou 4
Hải Dương 4
Kingston 4
Kyiv 4
Lanzhou 4
Seattle 4
Shanghai 4
Sydney 4
Amsterdam 3
Atlanta 3
Betim 3
Boston 3
Campinas 3
Dearborn 3
Detroit 3
Totale 3.091
Nome #
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 232
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 216
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 216
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 215
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 196
PD-L1 expression in lung non small cell carcinoma: evaluation of heterogeneity and definition of bioptic criteria for improving patients selection 181
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 180
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors 177
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 175
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 175
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 174
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions 171
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma 170
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification 164
Artificial intelligence in head and neck cancer diagnosis 161
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 155
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 152
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists 152
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 149
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 146
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 139
Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome 136
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 136
Delphi expert consensus for whole slide imaging in thyroid cytopathology 129
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 125
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability 122
PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays 121
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 115
Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker 111
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 104
PD-L1 expression heterogeneity in non-small cell lung cancer: defining criteria for harmonization between biopsies and whole sections 103
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 89
Natural Language Processing to extract SNOMED-CT codes from pathological reports 86
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est) 77
AIDA: AI-Driven Intelligent Diagnostics and Analytics 46
The evolution of prostate cancer grading: from Gleason score to risk taxonomy and the artificial intelligence revolution 6
Totale 5.202
Categoria #
all - tutte 17.476
article - articoli 15.280
book - libri 0
conference - conferenze 1.740
curatela - curatele 0
other - altro 456
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.952


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 0 0 19
2021/2022233 27 51 3 44 8 8 8 12 7 5 15 45
2022/2023520 30 53 44 93 41 135 16 26 60 6 16 0
2023/2024264 6 15 34 36 26 50 7 18 7 22 37 6
2024/2025781 30 41 40 131 54 55 33 21 108 44 75 149
2025/20262.491 155 126 161 431 614 157 202 142 206 165 74 58
Totale 5.202